Dachaigh › Lymphoma Cealla Mòra Anaplastic
Sgrùdaidhean clionaigeach Lymphoma Cealla Mòra Anaplastic a’ fastadh anns na SA
Tha 14 sgrùdaidhean airson Lymphoma Cealla Mòra Anaplastic a’ fastadh phàirtichean aig làraichean air feadh nan Stàitean Aonaichte.
Bailtean leis na sgrùdaidhean as motha
- Houston, TX4 sgrùdaidhean
- Atlanta, GA4 sgrùdaidhean
- St. Louis, MO4 sgrùdaidhean
- Durham, NC4 sgrùdaidhean
- Rochester, MN4 sgrùdaidhean
- Philadelphia, PA3 sgrùdaidhean
- Boston, MA3 sgrùdaidhean
- New York City, NY3 sgrùdaidhean
- Baldwin Park, CA3 sgrùdaidhean
- Seattle, WA3 sgrùdaidhean
- Columbus, OH3 sgrùdaidhean
Le stàit
- Arizona3 sgrùdaidhean
- California4 sgrùdaidhean
- Florida3 sgrùdaidhean
- Georgia4 sgrùdaidhean
- Illinois3 sgrùdaidhean
- Massachusetts3 sgrùdaidhean
- Minnesota4 sgrùdaidhean
- Missouri4 sgrùdaidhean
- New Jersey3 sgrùdaidhean
- New York5 sgrùdaidhean
- North Carolina5 sgrùdaidhean
- Ohio3 sgrùdaidhean
- Pennsylvania4 sgrùdaidhean
- Texas5 sgrùdaidhean
- Washington3 sgrùdaidhean
- Wisconsin3 sgrùdaidhean
Sgrùdaidhean air an ùrachadh o chionn ghoirid
Teacsa sgrùdaidh oifigeil (Beurla)
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
A’ fastadhÌre 1
Aoisean 12 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06176690A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
A’ fastadhÌre 1/2
Suas gu aois 25 · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04094610Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06561048Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06724237Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL)
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT07750886Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Iuch 2026 · NCT06508463Registry of Older Patients With Cancer
A’ fastadhSgrùdadh amharc
Aoisean 65 agus nas sine · Gach gnè · Air ùrachadh 29 Ògmh 2026 · NCT01137825A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Ògmh 2026 · NCT03017820Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
A’ fastadhÌre 2Fàilte do shaor-thoilich fhallain
6 Months · Gach gnè · Air ùrachadh 29 Cèit 2026 · NCT04195633A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Cèit 2026 · NCT07001384A Registry for People With T-cell Lymphoma
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT05978141Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCL
A’ fastadhÌre 2
Aoisean 1 gu 39 · Gach gnè · Air ùrachadh 20 Cèit 2026 · NCT07013565Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Gibl 2026 · NCT05544968Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 27 Dàmh 2025 · NCT01137643Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.